Literature DB >> 29574282

The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma.

Xian Lu1, Guanqun Wo2, Binghua Li1, Chun Xu2, Junhua Wu3, Chunping Jiang4, Jiwu Wei5.   

Abstract

The NF-κB/IL-6/STAT3 inflammatory axis is highly activated in a variety of inflammation-related cancers and contributes to suppression of antitumor immunity. In this study, we generated a novel herbal formula NHE-06, a water-decocting extract from six natural herbals, Ficus carica, Taraxacum mongolicum, Angelica sinensis, Lonicera japonica, Pseudo-ginseng and Folium ginkgo. We investigated the anti-inflammatory properties of NHE-06 and its antitumor efficacy in hepatocellular carcinoma, a typical inflammation-related cancer. We found that NHE-06 effectively suppressed NF-κB/IL-6/STAT3 signaling and enhanced antitumor immunity both in vitro and in HCC-bearing mice. In a subcutaneous HCC mouse model, we found that NHE-06 possessed both preventive and therapeutic functions. Moreover, rather than the cytotoxic effects, the antitumor efficacy of NHE-06 was indispensable of intact immunity, since the therapeutic effect was only achieved in immunocompetent mice whereas failed in immunocompromised mice. Taken together, the novel formula of the anti-inflammatory NHE-06 effectively restores antitumor immunosurveillance and can be applied for prevention and/or treatment of inflammation-related cancers.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antitumor immunity; Hepatocellular carcinoma; NF-κB/IL-6/STAT3 axis; Natural herbal extract

Mesh:

Substances:

Year:  2018        PMID: 29574282     DOI: 10.1016/j.biopha.2018.03.099

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Antitumor Effect of Pseudolaric Acid B Involving Regulation of Notch1/Akt Signaling Response in Human Hepatoma Cell In Vitro.

Authors:  Haijun Gao; Yan Zhang; Xiaojin Mo; Lele Huo; Yanping Luo; Ting Zhang; Xingming Ma; Wei Hu; Tao Jing
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-14       Impact factor: 2.650

2.  Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network.

Authors:  Wenbiao Chen; Jingjing Jiang; Peizhong Peter Wang; Lan Gong; Jianing Chen; Weibo Du; Kefan Bi; Hongyan Diao
Journal:  DNA Cell Biol       Date:  2019-08-29       Impact factor: 3.311

Review 3.  Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity.

Authors:  Wentao Jia; Lina Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-11       Impact factor: 2.629

Review 4.  IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma.

Authors:  Junnv Xu; Haifeng Lin; Gang Wu; Mingyue Zhu; Mengsen Li
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

5.  Mechanism of Yinqin Oral Liquid in the Treatment of Chronic Pharyngitis Based on Network Pharmacology.

Authors:  Shiliang Ji; Fei Xu; Ruifang Zhu; Cheng Wang; Dongkai Guo; Yiguo Jiang
Journal:  Drug Des Devel Ther       Date:  2021-10-20       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.